Cadence Pharmaceuticals, Inc. - Financial and Strategic Analysis Review
http://www.companiesandmarkets.com/Summary-Company-Profile/cadence-pharmaceuticals,-inc.-financial-and-strategic-analysis-review-85419.asp
- Market - Healthcare and Medical
- Published Date - 13/06/2009
- Report Type - Company Profile
- Country - Global
- Number of Pages - 14
- Electronic - £73.00
- Site Licence - £146.00
- Corporate Licence - £218.00
Report Summary
Cadence Pharmaceuticals, Inc. - Financial and Strategic Analysis Review
Summary
Cadence Pharmaceuticals, Inc. (Cadence) is a biopharmaceutical company principally engaged in in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. Its late-stage product candidates include Acetavance and Omigard. The company has its operation spread across the US. The company is headquartered at San Diego in California, United States.
The Cadence Pharmaceuticals, Inc. - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Cadence Pharmaceuticals, Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.
Scope
- Provides key company information for business intelligence needs.
- The company’s strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
- The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
- The report contains critical company information – business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
- The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
- Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Reasons to buy
- A quick "one-stop-shop" to understand the company.
- Enhance business/sales activities by understanding customers’ businesses better.
- Get detailed information and financial and strategic analysis on companies operating in your industry.
- Identify prospective partners and suppliers – with key data on their businesses and locations.
- Capitalize on competitor's weaknesses and target the market opportunities available to them.
- Compare your company’s financial trends with those of your peers / competitors.
- Scout for potential acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Table of Contents
Table Of Contents
Table Of Contents 2
List of Tables 3
List of Figures 3
Key Facts 4
Business Description 4
Major Products and Services 5
History 5
SWOT Analysis 6
SWOT Analysis - Overview 6
Cadence Pharmaceuticals, Inc. - Strengths 6
Cadence Pharmaceuticals, Inc. - Strengths - Focused on Market for Injectable Analgesics 6
Cadence Pharmaceuticals, Inc. - Strengths - Lead Product Candidate-Acetavance 6
Cadence Pharmaceuticals, Inc. - Weaknesses 6
Cadence Pharmaceuticals, Inc. - Weaknesses - Failure of Clinical Trials for Omigard 6
Cadence Pharmaceuticals, Inc. - Weaknesses - Lack of Patent Protection for Active Ingredients 6
Cadence Pharmaceuticals, Inc. - Weaknesses - History of Operating Losses 6
Cadence Pharmaceuticals, Inc. - Opportunities 6
Cadence Pharmaceuticals, Inc. - Opportunities - The Growing Hospital Use Drug Market 6
Cadence Pharmaceuticals, Inc. - Opportunities - Rising Healthcare Expenditure in the US 7
Cadence Pharmaceuticals, Inc. - Opportunities - Changing Demographics 7
Cadence Pharmaceuticals, Inc. - Threats 7
Cadence Pharmaceuticals, Inc. - Threats - Increasing Competition 7
Cadence Pharmaceuticals, Inc. - Threats - Dependence on Licensing Agreements 7
Cadence Pharmaceuticals, Inc. - Threats - Reliance on the Third Party Manufacturers 7
Key Competitors 8
Key Employees 8
Key Employee Biographies 9
Locations And Subsidiaries 9
Locations And Subsidiaries - Head Office 9
Financial Ratios 10
Financial Ratios - Capital Market Ratios 10
Financial Ratios - Annual Ratios 10
Financial Ratios - Interim Ratios 10
Financial Ratios - Ratio Charts 11
Appendix 12
Methodology 12
Ratio Definitions 12
About Global Markets Direct 15
Contact Us 15
Disclaimer 15
List of Tables
Cadence Pharmaceuticals, Inc., Key Facts 4
Major Products and Services 5
Cadence Pharmaceuticals, Inc., History 5
Cadence Pharmaceuticals, Inc., Key Employees 8
Cadence Pharmaceuticals, Inc., Key Employee Biographies 9
Cadence Pharmaceuticals, Inc., Ratios based on current share price 10
Cadence Pharmaceuticals, Inc., Annual Ratios 10
Cadence Pharmaceuticals, Inc., Interim Ratios 10
Currency Codes 12
Capital Market Ratios 12
Equity Ratios 13
Profitability Ratios 13
Cost Ratios 13
Liquidity Ratios 14
Leverage Ratios 14
Efficiency Ratios 14
List of Figures
Cadence Pharmaceuticals, Inc., Ratio Charts 11